Bottom line: Practical notes on between-session care — operations, outcomes, AI safety, integration, compliance, and policy.
Insights, research, and strategy on mental health, AI, and client-owned care.
We asked retreat leaders, integration therapists, and clinic directors one question: where does AI belong in psychedelic-assisted therapy? The answer shaped Asendar™ — technology that sits upstream of care, never inside the room, and never claiming authority over someone's inner experience.
HHS and White House signals suggest faster psychedelic access may be coming—but scaling psychedelic-assisted therapy on retrofit outpatient tools hits predictable walls. Here is why clinic readiness is operational, what failure modes look like at volume, and how Asendar™ is built for the pathway—not the 50-minute hour—with the Asendar™ App for client integration.
AI should not replace therapists. It should reduce note burden, surface contraindication risk, and support proactive follow-up so clinicians can stay present for psychedelic-assisted therapy.
The 50-minute hour doesn’t map to six- to ten-hour medicine sessions. Here’s how high-fidelity documentation, staffing handoffs, touch-contract logging, wearable-aware safety, and integration synthesis fit together—without breaking the container of care.
A perfect storm in mental health, the human toll on youth and veterans, and a 2026 policy shift toward supervised access. Why psychedelic-assisted therapy is framed as structural repair—not another bucket—and how Asendar™ App is built for the voyage after the drydock.
Durable change depends on preparation, the neuroplastic window, and structured integration—not disconnected visits. Here’s how Asendar™’s client-directed, team-coordinated model runs the program layer generic EHRs were never built for.
Phase 3 trials are moving, targets are diversifying beyond TRD, and dosage, setting, and evidence-grade reporting are becoming baseline. Here’s why the infrastructure moment is now—and how Asendar™ App is built for both plant and pharmaceutical tracks.
Texas SB 2308 puts ibogaine into an HHSC-led trials framework. The state needs an evidence engine—not spreadsheets. Asendar™ App is built as Program OS + Reporting Pack for consortium partners and oversight.
Digital twins are the defining healthcare trend of 2026. Here’s how psychedelic clinics can lead with AI-powered, living models that predict risk and personalize care.
The hardware of the mental health revolution has arrived. But the software hasn’t caught up. Here’s why the next wave of psychedelic care depends on purpose-built infrastructure.
Join our newsletter for updates on AI-powered therapy, blockchain compliance, and next-generation client outcomes.
Free to try, no paywall — your companion for the moments between sessions.